跳至主要内容
临床试验/TCTR20210218002
TCTR20210218002尚未招募1 期

The effect of melatonin in the improvement of the symptoms in irritable bowel syndrome patients with sleep disturbance

Ratchadapiseksompotch Research Fund0 个研究点目标入组 28 人开始时间: 2021年2月18日最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
28

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • 1. Patients age 18 years or more
  • 2. The patients who have symptoms of irritable bowel syndrome at least 3 months before registry
  • 3. The symptoms of IBS disturb activity daily life
  • 4. Have sleep disturbance (Pittsburgh sleep quality index at least 5)
  • 5. give the inform consent

排除标准

  • 1. Pregnancy or lactation
  • 2. History surgery of gastrointestinal tract
  • 3. History of neurological disorder
  • 4. History of organic disease of gastrointestinal tract, liver disease, diabetes
  • 5. shift worker
  • 6. Taking sleeping pill within 2 weeks before registry
  • 7. poor compliance

研究者

发起方
Ratchadapiseksompotch Research Fund

相似试验